RYVLX
Price
$697.57
Change
+$28.85 (+4.31%)
Updated
Oct 13 closing price
Net Assets
1.35B
TEPSX
Price
$35.46
Change
+$1.24 (+3.62%)
Updated
Oct 13 closing price
Net Assets
97.4M
Interact to see
Advertisement

RYVLX vs TEPSX

Header iconRYVLX vs TEPSX Comparison
Open Charts RYVLX vs TEPSXBanner chart's image
Rydex NASDAQ-100® 2x Strategy A
Price$697.57
Change+$28.85 (+4.31%)
VolumeN/A
Net Assets1.35B
ProFunds Technology UltraSector Svc
Price$35.46
Change+$1.24 (+3.62%)
VolumeN/A
Net Assets97.4M
RYVLX vs TEPSX Comparison Chart in %
View a ticker or compare two or three
VS
RYVLX vs. TEPSX commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVLX is a Buy and TEPSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.35B vs. TEPSX (97.4M). RYVLX (0.00) and TEPSX (0.00) have matching dividends . RYVLX was incepted earlier than TEPSX: RYVLX (21 years) vs TEPSX (25 years). TEPSX (2.55) is less costly to investors than RYVLX (1.87). RYVLX is a more actively managed with annual turnover of: 383.00 vs. TEPSX (116.00). RYVLX has a lower initial minimum investment than TEPSX: RYVLX (2500) vs TEPSX (15000). RYVLX annual gain was more profitable for investors over the last year : 21.39 vs. TEPSX (9.52). RYVLX return over 5 years is better than : 111.05 vs. TEPSX (89.45).
RYVLXTEPSXRYVLX / TEPSX
Total Expense Ratio1.742.5568%
Annual Report Gross Expense Ratio1.872.5573%
Fund Existence21 years25 years-
Gain YTD21.46023.89690%
Front Load5%N/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B97.4M1,382%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.399.52225%
Returns for 3 years259.08165.68156%
Returns for 5 years111.0589.45124%
Returns for 10 years781.63676.85115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVGGF75.180.18
+0.24%
Evolution AB
SEOVF0.13N/A
N/A
SERNOVA BIOTHERAPEUTICS INC.
CGECF42.83N/A
N/A
Cogeco Inc.
CFMOF62.18N/A
N/A
Cofinimmo S.A.
NASC0.02N/A
-2.36%
Nascent Pharma Holdings Inc.